Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association
…, NG Clark, MJ Franz, BJ Hoogwerf… - Diabetes …, 2008 - pubmed.ncbi.nlm.nih.gov
… American Diabetes Association; John P Bantle, Judith Wylie-Rosett, Ann L Albright,
Caroline M Apovian, Nathaniel G Clark, Marion J Franz, Byron J Hoogwerf, Alice H …
Caroline M Apovian, Nathaniel G Clark, Marion J Franz, Byron J Hoogwerf, Alice H …
Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy: Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22
…, RP Murphy, K Chantry, BJ Hoogwerf… - Archives of …, 1996 - jamanetwork.com
Objective: To evaluate the relationship between serum lipid levels, retinal hard exudate, and
visual acuity in patients with diabetic retinopathy. Design: Observational data from the Early …
visual acuity in patients with diabetic retinopathy. Design: Observational data from the Early …
Use of twice-daily exenatide in basal insulin–treated patients with type 2 diabetes: a randomized, controlled trial
…, AYM Kwan, BJ Hoogwerf, J Rosenstock - Annals of internal …, 2011 - acpjournals.org
Background: Insulin replacement in diabetes often requires prandial intervention to reach
hemoglobin A 1c (HbA 1c ) targets. Objective: To test whether twice-daily exenatide injections …
hemoglobin A 1c (HbA 1c ) targets. Objective: To test whether twice-daily exenatide injections …
Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial
…, HC Gerstein, V Fonseca, JL Fleg, BJ Hoogwerf… - Diabetes …, 2010 - Am Diabetes Assoc
OBJECTIVE Intensive therapy targeting normal blood glucose increased mortality compared
with standard treatment in a randomized clinical trial of 10,251 participants with type 2 …
with standard treatment in a randomized clinical trial of 10,251 participants with type 2 …
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
…, SK Shenouda, CR Heilmann, BJ Hoogwerf… - The Lancet, 2013 - thelancet.com
Background Glucagon-like peptide-1 receptor agonists exenatide and liraglutide have been
shown to improve glycaemic control and reduce bodyweight in patients with type 2 diabetes. …
shown to improve glycaemic control and reduce bodyweight in patients with type 2 diabetes. …
The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes: a randomized trial
B Zinman, BJ Hoogwerf, S Durán García… - Annals of internal …, 2007 - acpjournals.org
Background: Exenatide therapy is effective in combination with metformin or sulfonylureas
for treating type 2 diabetes. Thiazolidinediones (TZDs) also are commonly used, but the …
for treating type 2 diabetes. Thiazolidinediones (TZDs) also are commonly used, but the …
[HTML][HTML] Efficacy of GLP-1 receptor agonists and DPP-4 inhibitors: meta-analysis and systematic review
…, W Huang, MB DeYoung, T Darsow, BJ Hoogwerf - Clinical …, 2012 - Elsevier
BACKGROUND: Considerable clinical data on the treatment of type 2 diabetes with incretin-based
therapies (glucagon-like peptide 1 receptor agonists [GLP-1RAs] and dipeptidyl-…
therapies (glucagon-like peptide 1 receptor agonists [GLP-1RAs] and dipeptidyl-…
Postprandial glucose and insulin responses to meals containing different carbohydrates in normal and diabetic subjects
…, GW Castle, JW Thomas, BJ Hoogwerf… - … England Journal of …, 1983 - Mass Medical Soc
To examine whether the form of dietary carbohydrate influences glucose and insulin
responses, we studied the glucose and insulin responses to five meals — each containing a …
responses, we studied the glucose and insulin responses to five meals — each containing a …
Nutrition principles for the management off diabetes and related complications
…, AM Coulston, RR Henry, BJ Hoogwerf… - Diabetes …, 1994 - Am Diabetes Assoc
Health professionals and people with diabetes recognize nutrition therapy as one of the
most challenging aspects of diabetes care and education (1). Adherence to meal planning …
most challenging aspects of diabetes care and education (1). Adherence to meal planning …
Neuroglycopenic and other symptoms in patients with insulinomas
AM Dizon, S Kowalyk, BJ Hoogwerf - The American journal of medicine, 1999 - Elsevier
PURPOSE: To characterize neuroglycopenic symptoms in the clinical presentation of patients
with insulinomas. SUBJECTS AND METHODS: Patients with histologically confirmed islet …
with insulinomas. SUBJECTS AND METHODS: Patients with histologically confirmed islet …